These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 17964912
1. Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes? Joffe D, Yanagisawa RT. Med Clin North Am; 2007 Nov; 91(6):1107-23, ix. PubMed ID: 17964912 [Abstract] [Full Text] [Related]
2. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes. Caballero AE. J Diabetes Complications; 2009 Nov; 23(2):143-52. PubMed ID: 18413192 [Abstract] [Full Text] [Related]
3. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction. Lee M, Aronne LJ. Am J Cardiol; 2007 Feb 19; 99(4A):68B-79B. PubMed ID: 17307059 [Abstract] [Full Text] [Related]
4. Treatment of diabetes in patients with severe obesity. Scheen AJ. Biomed Pharmacother; 2000 Mar 19; 54(2):74-9. PubMed ID: 10759290 [Abstract] [Full Text] [Related]
5. Insulin treatment and the problem of weight gain in type 2 diabetes. Carver C. Diabetes Educ; 2006 Mar 19; 32(6):910-7. PubMed ID: 17102158 [Abstract] [Full Text] [Related]
6. Prevention of diabetes development in those with the metabolic syndrome. Tupper T, Gopalakrishnan G. Med Clin North Am; 2007 Nov 19; 91(6):1091-105, viii-ix. PubMed ID: 17964911 [Abstract] [Full Text] [Related]
7. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations. Gottesman I. Diabetes Res Clin Pract; 2004 Sep 19; 65 Suppl 1():S17-22. PubMed ID: 15315866 [Abstract] [Full Text] [Related]
9. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? Bays H, Blonde L, Rosenson R. Expert Rev Cardiovasc Ther; 2006 Nov 19; 4(6):871-95. PubMed ID: 17173503 [Abstract] [Full Text] [Related]
10. The effects of pharmacologic agents for type 2 diabetes mellitus on body weight. Pi-Sunyer FX. Postgrad Med; 2008 Jul 19; 120(2):5-17. PubMed ID: 18654064 [Abstract] [Full Text] [Related]
11. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes. Viberti G. J Diabetes Complications; 2005 Jul 19; 19(3):168-77. PubMed ID: 15866064 [Abstract] [Full Text] [Related]
12. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Heller S. Diabetes Res Clin Pract; 2004 Sep 19; 65 Suppl 1():S23-7. PubMed ID: 15315867 [Abstract] [Full Text] [Related]
13. Does metabolic syndrome influence psoriasis? Saraceno R, Ruzzetti M, De Martino MU, Di Renzo L, Cianci R, De Lorenzo A, Chimenti S. Eur Rev Med Pharmacol Sci; 2008 Sep 19; 12(5):339-41. PubMed ID: 19024221 [Abstract] [Full Text] [Related]
14. Diabetes medications and body weight. Mitri J, Hamdy O. Expert Opin Drug Saf; 2009 Sep 19; 8(5):573-84. PubMed ID: 19538102 [Abstract] [Full Text] [Related]
15. Cardiovascular risk in the spectrum of type 2 diabetes mellitus. Ahmed I, Goldstein BJ. Mt Sinai J Med; 2006 Sep 19; 73(5):759-68. PubMed ID: 17008936 [Abstract] [Full Text] [Related]
16. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease. Levy P. Postgrad Med; 2009 May 19; 121(3 Suppl 1):7-12. PubMed ID: 19494472 [Abstract] [Full Text] [Related]
17. Use of insulin and weight gain: optimizing diabetes nutrition therapy. Daly A. J Am Diet Assoc; 2007 Aug 19; 107(8):1386-93. PubMed ID: 17659906 [Abstract] [Full Text] [Related]
18. Thiazolidinediones, insulin resistance and obesity: Finding a balance. Wilding J. Int J Clin Pract; 2006 Oct 19; 60(10):1272-80. PubMed ID: 16981971 [Abstract] [Full Text] [Related]
19. Early pharmacological intervention in newly diagnosed metabolic syndrome and type 2 diabetes. Naruszewicz M. Przegl Lek; 2006 Oct 19; 63 Suppl 4():7-8. PubMed ID: 16967707 [No Abstract] [Full Text] [Related]